ALX Oncology Holdings Inc Ordinary Shares ALXO
News
ALX Oncology to Present at Upcoming Investor Conferences
ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer
ALX Oncology to Present at Upcoming Investor Conferences in September
